AIM ImmunoTech Inc Investor Summer Spotlight Series Transcript
Hello, and thank you for joining us for the next company spotlight on day two of the Virtual Investor: Summer Spotlight Series. This is a three-day event spotlighting some very exciting companies. My name is Jenene Thomas, I am CEO of JTC IR, and I will be the moderator for today's event.
I am pleased to be joined by Tom Equels, Chief Executive Officer; and Dr. Chris McAleer; Scientific Officer at AIM ImmunoTech. So welcome, gentlemen. So glad to have you back on our platform.
Thank you, Jenene, it's a pleasure to be here.
Glad to be here.
Wonder. So just a few housekeeping items before we get started. I just want to inform our audience that AIM ImmunoTech is public listed on the NYSE American and trades under the ticker AIM. And during today's discussion, the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
